Abstract
Tapentadol hydrochloride of formula I, a centrally-acting analgesic compound, is chemically known as 3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2methylpropyl]phenol monohydrochloride and marketed under the trade name Nucynta®. The present invention provides an alternative process for the preparation of Tapentadol hydrochloride.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
"Process for the preparation of Tapentadol hydrochloride", Technical Disclosure Commons, (March 14, 2022)
https://www.tdcommons.org/dpubs_series/4964
COinS